Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the ...

Anthropic introduced a new application programming interface (API) feature on Thursday to let developers ground the responses ...

The stock of Vertex Pharmaceuticals Incorporated VRTX has declined almost 13% in the past six months. A key reason for the stock price decline was unimpressive data from a phase II study on its key ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We've got lots ...

As a result of its emergence from chapter 11, Vertex will operate as a privately-held company under the ownership of certain of Vertex’s lenders, including funds managed by BlackRock Financial ...

This collaboration is set to revolutionize the industrial mobile communications landscape by introducing intrinsically safe ...

Vertex won FDA approval for its newest CF drug, Alyftrek on Dec. 20, 2024. This therapy seems likely to become the new standard of care for CF with its powerful efficacy and convenient once-per-day ...

Please provide your email address to receive an email when new articles are posted on . Percent-predicted FEV 1, sweat chloride and safety were analyzed in two phase 3 trials of vanzacaftor ...

The Royal Standard represents the Sovereign and the United Kingdom. The Royal Standard is flown when The King is in residence in one of the Royal Palaces, on The King's car on official journeys and on ...

Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through ...

Credit: da-kuk via Getty Images. Vertex Pharmaceuticals and Orna Therapeutics have announced a three-year collaboration to develop next-generation gene therapies for sickle cell disease (SCD) and ...